Introduction
============

At present, it is well known that the production of new neurons in the mammalian brain is not restricted to the embryonic and early postnatal development stages, but occurs throughout the lifespan of animals. However, not all brain regions are equally capable of generating new neurons. There are two main neurogenic niches where neurogenesis persists: the ventricular-subventricular zone (V-SVZ) and the subgranular zone of the hippocampus (SGZ). By the term V-SVZ we mean a complex of brain regions that includes: the subventricular zone (SVZ) -- the area stretching along the lateral wall of the lateral ventricles, the ventral extension of the lateral ventricles, and the posterior periventricular region (PPV). Several researchers have also considered these areas as a single neurogenic zone ([@B91]; [@B112]). During adulthood, neurogenesis also occurs in several other brain regions, including the striatum ([@B99], [@B101]) and cortex ([@B54]; [@B27]). At the same time, in mice, the most well-studied mammalian species, under physiological conditions no neurogenesis occurs in the cortex ([@B38]) and striatum ([@B164]; [@B100]; [@B121]) or, probably, it occurs but only at a very low rate.

Some types of brain damage, such as ischemia or traumatic brain injury (TBI), stimulate neurogenesis in the brain ([@B158]; [@B106]). On the one hand, we know that the proliferation of neuronal precursors (NPCs) in the V-SVZ (the most active proliferative region of the brain) increases, and that these precursors migrate from their place of origin to the injury site ([@B120]; [@B64]; [@B176]). On the other hand, many studies have shown that when the brain is damaged, new neurons are generated from local neural stem cells (NSCs) at the injury site ([@B128]; [@B104]; [@B121]). This raises the question: do the NPCs that migrate from the V-SVZ play a major role in the injury-related neurogenesis, or is the role of resident NPCs more important? The answer to this question is of huge clinical significance, because it will determine treatment methods targeted either at the increase in localized neurogenesis near the injury site or at the increase in neurogenesis in -- and migration from -- the V-SVZ. Consequently, numerous studies have been carried out to establish the dynamics of proliferation and migration of NPCs in the brain in various conditions. In the present review we consider the studies with a focus on the features of neurogenesis in conditions of ischemia and TBI.

Methods for Studying the Production and Migration of NPCs
=========================================================

Here we consider approaches to studying neurogenesis, paying particular attention to how the origin of new neurons can be established. In other words, whether new neurons have originated in the same area where they localize, or if they/their precursors have migrated there from another area. Methods for defining migration pathways of NPCs are also reviewed here.

Research Into Spatial Distribution of Neuronal Precursors in Fixed Brain Tissues
--------------------------------------------------------------------------------

Historically, the first studies that established the production of new neurons in the mammalian brain were performed using autoradiographic investigation of 3H-thymidine-labeled dividing cells, in particular, newborn neurons ([@B5]; [@B66]; [@B50]). However, neurogenesis in the adult mammalian brain has not been acknowledged by the scientific community for a long time. The existence of neurogenesis was recognized only after methodological improvement, which promoted further studies. This improvement was replacement of radioactive analog of thymidine with bromodeoxiuridine (BrdU), which can be detected by immunohistochemistry ([@B2]).

This approach, based on the administration of such proliferation markers as BrdU and other analogs of thymidine, still remains among the most widely used methods. BrdU can be administered intraperitoneally or with drinking water. It incorporates into the cells that are in S-phase at the time of administration. The timing of BrdU administration and subsequent killing of animals affect the interpretation of results. When BrdU is given systematically for several days or weeks, labeled cells born at different time points cannot be distinguished. Alternatively, a single dose (pulse) of BrdU labels the cells that are born at the time of the pulse. Then animals can be sacrificed either shortly after administration, or at a delayed time point (pulsed and pulse-chase paradigm, respectively). This approach allows for the tracing of a short-term or a long-term fate of a particular group of cells that are born at a certain time point ([@B27]; [@B161]; [@B150]; [@B98]).

In addition to BrdU, other nucleotide analogs can be used: -5-chloro-20-deoxyuridine (CldU), 5-iodo-20-deoxyuridine (IdU), and 5-ethynyl-20-deoxyuridine (EdU). The use of combination of several thymidine analogs within the same experiment gives additional possibilities. Labeling of dividing cells with two ([@B40]) or even three ([@B139]) nucleotide analogs allows for measuring cell-division kinetics, and identifying and tracing subclasses of NSCs or NPCs. Assessment of the fraction of CldU/IdU double-labeled NPCs enabled [@B40] to determine the number of divisions, the length of S-phase, and the length of the division cycle of amplifying and quiescent neural progenitors in the dentate gyrus (DG).

The immunodetection of BrdU or other thymidine analogs in fixed brain slices, in combination with labeling the specific markers of immature (doublecortin or DCX) and mature (NeuN, MAP2, NSE) neurons, as well as NSCs (Nestin, SOX2), allows for indirect tracking of NPCs. Additionally, Ki67, a marker of cell divisions, is used to confirm the proliferation status and to identify the location of non-migrating progenitors ([@B2]; [@B79]).

Although this approach facilitated the estimation of the proliferation and differentiation of NPCs, it provided only indirect evidence of neuroblast migration. The signs of migration can be: a distribution pattern of migrating neuroblasts (markers -- DCX and sometimes PSA-NCAM) from the place of origin toward the place of destination ([@B132]), a density gradient of neuroblasts with high density at the presumed place of origin ([@B165]; [@B47]), as well as the change in this gradient at subsequent time points ([@B177]; [@B131]; [@B90]). Also, in their works researchers pay due attention to the orientation of migrating cells. Neuroblasts stretch out their leading processes in the direction of the zone to which they are moving ([@B134]; [@B190]; [@B27]; [@B130]; [@B119]; [@B113]). Moreover, migrating neuroblasts often integrate into chains, and the orientation of the chain also corresponds to the direction of migration ([@B134]; [@B190]; [@B173]; [@B78]; [@B179]; [@B67]; [@B171]; [@B154]). Alternatively, clustering cells with round cell bodies, lacking long leading processes and co-expressing DCX with proliferation marker Ki67 are considered as non-migrating local NPCs ([@B104]; [@B121]).

Studies of postmortem tissues are of great importance in research on human neurogenesis because this is the only way it can be investigated. BrdU labeling in combination with other neuronal markers enabled scientists to prove for the first time the existence of neurogenesis in humans ([@B41]). A more sophisticated technique of ^14^C-dating was proposed by Jonas Frisen's group ([@B13]; [@B156]). The technique is based on the fact that the ^14^C levels in the atmosphere have been decreasing at a known rate since a sharp rise in the ^14^C content caused by the extensive testing of nuclear weapons in the middle of the 20th centuary. Thus, comparison of the ^14^C-content in DNA with that in the atmosphere enabled the assessment of the age of cells. Isolation of cell nuclei from brain tissue with subsequent labeling with NeuN and the ^14^C content measuring by accelerator mass spectrometry allowed for evaluation of the turnover rate of neurons in the human hippocampus, cortex, olfactory bulb (OB), and striatum ([@B13]; [@B156]; [@B42]).

The above-mentioned studies have investigated neuroblasts distribution in brain slices. The limitation of this approach is a lack of information about whole brain tissues. In recent years, completely new techniques for *ex vivo* studies which potentially expand possibilities for the investigation of new neuron generation have been devised.

A promising technique called CLARITY ([@B22]) was developed by the Deisseroth lab. This technique makes the entire brain transparent for any optical imaging via special chemical transformations of intact brain tissue. These transformations aim to remove the lipid component of the brain while retaining the protein and nucleic components in their native state. After transformation, the preserved components can either be immunohistochemically stained or initially fluorescent-labeled by genetic modification, thereby facilitating the performance of precise whole-brain imaging without dividing into slices. Imaging of the whole brain rather than of just separate brain slices could provide an entire picture of the spatial distribution and orientation of migrating NPCs.

Despite the unique possibility to obtain 3D images of brain structure at the molecular level, we did not find any research works that have used this method since it was published. The major limitations of this method are the complexity and timescales involved in the brain processing and immunostaining, as well as the toxicity of the reagents used ([@B62]). Significant efforts have been made to improve this technique ([@B62]) in order that it might be more extensively used in studies -- including NPC tracking.

Another powerful technique, single-cell transcriptomics, is based on measuring gene expression at the level of individual cells in certain cell populations. It helps clarify the mechanisms of cell reprogramming into NSCs in non-neurogenic zones after injury and promotes a better understanding of the balance of NSC activation and quiescent state in the neurogenic niches ([@B97]). Cell subgroups identified by this technique can be compared to the known cell types using previously established marker genes; however, novel cell subtypes can also be discovered using single-cell data ([@B94]). Unlike immunofluorescent detection with antibodies, which is usually limited in the number of markers, single-cell transcriptomics allows for the simultaneous investigation of hundreds, or even thousands, of genes. The main limitation of this technique in studies on cell migration is the loss of the original spatial context. Currently, efforts are being made to overcome this limitation by using computational methods of 3D reconstruction ([@B147]). Combining single-cell transcriptomics with other single-cell techniques, such as fluorescent RNA FISH, provides an orthogonal method of quantifying transcript levels, and is often used to independently validate results from scRNA-seq data ([@B94]).

In general, neuroblast distribution, orientation, morphology and clustering are only indirect signs of migration. Additionally, this approach is limited only to estimation of the origin and migration direction of cells, which at a certain time point are migrating neuroblasts. However, we lack information on the origin of new cells that have already become mature neurons. In the next section, we will discuss methods that allow us to specifically trace the fate of cells of a particular origin, i.e., the cells that originated from the SVZ or cortex.

Determining the Place/Time of NPCs Production by Chemical and Genetic Labeling
------------------------------------------------------------------------------

Local labeling of the cells within a particular region of the brain is a powerful method for tracing the migration of NPCs that are produced there. After labeling, the fate of the NPCs and their offspring can be examined at different time points. For example, these labeled cells can be found in a different brain region some time later, or they can stay at their place of origin. To determine a phenotype of stained cells, immunohistochemical detection of such cell type-specific proteins as DCX, calretinin, NeuN, MAP2, NSE, and Nestin is carried out ([@B120]; [@B64]; [@B194]; [@B49]; [@B142]; [@B188], [@B192]; [@B127]; [@B176]; [@B75]; [@B180], [@B181]; [@B43], [@B44]; [@B57]; [@B80]; [@B93]; [@B77]; [@B86]; [@B88]; [@B128]; [@B152]; [@B185]; [@B14]; [@B55]; [@B145]; [@B104]; [@B36]).

Local injection of various tracers into the brain is widely used. In this method, the cells residing in the zone of injection, absorb the tracer; this then allows for tracking the fate of these cells, or their offspring at different post-injection time points. Tracers can be either a stain ([@B120]; [@B64]; [@B194]; [@B142]; [@B188]; [@B43]; [@B57]; [@B152]), or a genetic vector, which after entering the cell causes expression of the marker in it ([@B120]; [@B57]; [@B80]; [@B104]; [@B36]).

For labeling brain cells, such stains as 1,1′-dioctadecyl-6,6′-di- (4-sulfophenyl)-3,3,3′,3′ tetramethylindocarbocyanine (DiI), and fluorescent latex microspheres are used. For detection of the labeled cells, fluorescent microscopy is used ([@B120]; [@B64]; [@B194]; [@B142]; [@B188]; [@B43]; [@B57]; [@B152]). However, the major drawback of this approach is that a cell gets a very limited amount of the label, which can then be lost either due to cell metabolism, or via cell divisions, if labeled cells are proliferating as in the case of NPCs. In this regard, a genetic vector injection is a more appropriate method because even one copy of a reporter gene entering the cell may be enough to cause a stable synthesis of labeling substance in it. Moreover, the application of such genetic vectors as retrovirus or lentivirus, which integrate into the host cell genome, ensures the transmission of the reporter gene to all offspring of the infected cell: this is an advantage for the staining of proliferating cells, for example, NPCs.

Genetic vectors for *in vivo* cells tracing encode many different reporter genes that allow for the identification of targeted cells. These include the green fluorescent protein (GFP) gene, the yellow fluorescent protein (YFP) gene, the DSRed, mCherry, and mKate for detection using fluorescence microscopy; the alkaline phosphatase (AP) gene for immunodetection; the galactosidase (GLA) gene for histochemical detection using transmitted light microscopy ([@B120]; [@B49]; [@B127]; [@B75]; [@B180], [@B181]; [@B57]; [@B80]; [@B93]; [@B86]; [@B128]; [@B185]; [@B55]; [@B145]; [@B104]; [@B115]; [@B169]; [@B36]; [@B29]).

Another important question concerns promoters that drive reporter gene expression in vectors for NPCs labeling. The use of general promoters (CMV-promoter, CAG-promoter) in the construct results in non-specific expression of the reporter gene in the cells that have been successfully infected with a genetic vector ([@B55]; [@B145]; [@B104]; [@B36]). Nevertheless, this promoter-related non-specificity may at least in part be compensated by the use of viral serotypes that preferentially target specific cell types ([@B9]), as well as by the use of retroviruses that transduce specifically mitotic cells ([@B144]). Non-specific expression is in fact an advantage, if the aim of investigation is to trace the cells' fate throughout their differentiation -- when changes in expression of many cell type-specific genes occur. The use of cell type-specific promoter drives expression of the reporter gene in a particular group of cells. It can be a promoter of the gene, the expression of which is a reliable indicator of a certain cell group; for example, DCX -- a protein of young neurons, Nestin -- of NSCs, GFAP -- of NSCs and astroglia. This approach has only a limited potential for studying neurogenesis as it does not allow for the detection of neural cells at different stages of their development.

Interestingly, there is still at least one work in which this approach was applied to investigate the origin of new neurons in the brain. [@B36] injected a plasmid carrying the GFP gene under the control of the GFAP gene promoter into the striatum of mice and showed that after ischemia new striatal neurons express the GFP-reporter, despite the lack of GFAP gene expression. The authors concluded that these new neurons in the striatum stem from local GFAP-expressing astrocytes. However, since it remains unclear what could be the cause of GFP expression in these new neurons, the results of the research cannot be unambiguously interpreted.

A completely different approach involves the use of transgenic animals already carrying a reporter gene in their cells. As a rule, the reporter gene is initially inactive because of an insertion containing a stop signal. It can then be restored (the restoration mechanisms are described below), thus facilitating the reconstruction of the reporter gene in the cells residing in a specific brain region at a specific time point and of a specific phenotype. Later, the cells where the reporter gene was restored and their offspring can be detected ([@B88]; [@B14]; [@B192]; [@B104]; [@B44]).

The reporter gene can be restored by the use of site-specific Cre-recombinase that removes an insertion from the reporter gene ([@B104]; [@B121]). A specific variant of this recombinase is a CreERT2 recombinase that requires the presence of tamoxifen for activity ([@B88]; [@B192]; [@B44]). Tamoxifen can be either administered intraperitoneally ([@B88]; [@B192]) or added to daily ration ([@B44]). The gene of Cre-recombinase recombinase can be initially present in the animal genome, together with the reporter gene ([@B88]; [@B192]; [@B44]). Alternatively, it can be introduced into the animal brain via vector injection ([@B104]). Additionally, to achieve cell-type specificity of the reporter gene restoration, the recombinase gene can be placed under the control of a cell-specific promoter, for example, the promoter of the GFAP gene ([@B104]; [@B121]). As a result of these manipulations, reporter gene restoration occurs in a particular brain region, or at least at a specific time point, and in the cells having a particular phenotype.

Lastly, [@B77] used animals carrying the reporter gene under the control of a promoter of the 5HT3A gene, which is active in all, or the majority, of neuroblasts originating from the SVZ, as well as in some mature interneurons. In combination with BrdU administration, it allows the distinguishing of SVZ-derived newborn cells.

Another principally new technique to have been recently developed is the Brainbow strategy ([@B95]) which aims to identify single cells of one type and trace their connections and lineages. The strategy is based on Cre-Lox recombination that allows the Brainbow transgene to cause expression of three different fluorescent proteins in random combinations and obtain multicolor micrographs of brain sections. Recently, this approach has been successfully applied to trace lineages of NSCs and NPCs in the DG and SVZ for 6 months ([@B51]). Obviously, this technique has huge potential since it helps distinguish ramified processes of neighboring cells and thereby trace their lineage. However, we believe that the advantages of the Brainbow technique are also its limitations because multicolor single-cell labeling cannot be combined with another type of fluorescent labeling.

Thus, local *in vivo* cell labeling is the most reliable method for establishing the origin of new neurons in brain regions. Rapid development in genetic engineering led to widespread using of plasmid libraries designed for new viral vector production. To increase efficiency of the use of libraries, a novel tool of viral barcoding was suggested ([@B26]). The method of *in vivo* cell labeling is often used together with detection of labeled cells in fixed brain sections. Additionally, this method facilitates observation of the migration of labeled neuroblasts in real time, as described in the section "Real-Time Observation of NPCs Migration."

Suppression of NPC Production and Migration
-------------------------------------------

In this section we describe approaches that diminish or exclude any participation of one brain region in the replenishment of neurons in another region. Two methods are applicable here: either locally suppressing the production of new NPCs in one region or preventing the migration of NPCs from one region to another.

Inhibition of neurogenesis in a particular brain region can be achieved by local injection of the antimitotic agent Ara-C, which kills cycling cells. In a number of studies, Ara-C was administered into the lateral ventricle. Thus the role of SVZ neurogenesis in the addition of new neurons in the damaged cortex was examined ([@B85]; [@B86]; [@B185]; [@B44]). In some works, migration from the SVZ toward the cortex was prevented by surgical separation ([@B150]; [@B3]).

However, it should be mentioned that some issues have complicated the interpretation of the results obtained with the use of these approaches. In particular, antimitotic drugs can diffuse in the brain tissue from the region of injection to remote brain areas. Thus, spatial specificity of antimitotic effect should be carefully verified. Additionally, both local antimitotic drug administration and surgical isolation of brain areas are highly invasive approaches, potentially causing unwanted side effects.

Almost all the above-mentioned studies have demonstrated that the suppression of proliferation in, or migration from, one region affects the number of new neurons in the other; therefore, the results of these experiments cannot be unequivocally interpreted ([@B85]; [@B150]; [@B86]; [@B185]; [@B44]).

Real-Time Observation of NPCs Migration
---------------------------------------

In the last few decades, new methods for longitudinal *in vivo* tracking of NPCs have been devised, while some existing ones have been considerably improved. One of those more recently developed approaches involves MRI-based labeling of migrating NPCs, while others are based on fluorescence or bioluminescence detection.

The most common MRI-based labeling technique uses iron oxide particles as MRI-negative contrast agent visible in T2-weighted images ([@B125]; [@B18]). Several efforts have been made to visualize NPCs by injecting iron oxide nanoparticles directly into the lateral ventricles or the SVZ ([@B149]; [@B133]; [@B123]; [@B157]; [@B170]). However, this method has several significant limitations: cells can release iron oxide particles that can then be absorbed by non-proliferating cells, including macrophages, which are present at the site of damage, thus indicating low specificity of the method; furthermore, neuroblasts can die before reaching the target regions ([@B174]). Consequently, MRI detection by iron-based nanoparticles does not provide precise information about the state, location and survival of new neurons.

Attempts to overcome low specificity of paramagnetic nanoparticles have been made in a number of works ([@B39]; [@B195]; [@B187]), in which the animal brain was injected with paramagnetic particles conjugated with antibodies to specific cell-surface antigens of NPCs. Another type of cell labeling for MRI is based on reporter genes coding paramagnetic proteins, mainly ferritin ([@B61]; [@B168]). This method, though less liable to imaging artifacts compared to iron oxide labeling, shows relatively low MR signal intensity from ferritin overexpression ([@B122]). Thus, the reporter gene design and MRI protocols need improving. A similar methodological approach utilizing specific reporter genes was applied for NPC visualization in other modalities. Introduction of the luciferase gene allowed the tracing of NPCs using bioluminescence detection ([@B143]; [@B169]).

Multiple works at different levels of observation were performed with the use of fluorescence. Neuroblast migration dynamics was directly observed on acute brain slices using time-lapse microscopy ([@B81]). In these works, migrating cells are also labeled either by prior administration of fluorescent particles ([@B193]) or a vector with a reporter gene ([@B60]; [@B73]; [@B83]; [@B55]) into the animal brain, or by using transgenic animals carrying the reporter gene under the control of a neuron-specific promoter ([@B28]; [@B191]). The advantage of studies on brain sections, when compared to research into the whole brain, is greater resolution and the possibility of a detailed estimation of particular cells' behavior. The limitation of this method is the short lifespan of a brain slice -- usually studies last up to one day. However, the living whole brain is preferred to long-living brain slices for observations at the molecular level.

The most promising strategy is a recently developed technique of *in vivo* cell tracking with intravital microscopy through a cranial window. Two-photon microscopy is a further improvement of confocal laser scanning microscopy due to its deeper tissue penetration, efficient light detection, and reduced photobleaching ([@B31]). These benefits allowed for the combination of this technique with intravital observation of living neural cells that had been previously labeled using reporter genes of fluorescent proteins. Recently this technique has been used for the investigation of hippocampal neurogenesis in the DG ([@B138]).

[Table 1](#T1){ref-type="table"} summarizes the advantages and limitations of the methods described in this section. From our point of view, the methods for local cell labeling and the methods for direct observation of cells, described in the sections "Determining the Place/Time of NPCs Production by Chemical and Genetic Labeling" and "Real-Time Observation of NPCs Migration," are the most promising, informative, and precise.

###### 

Methods for estimation of NPCs migration in the brain.

  Method                                                                Description of the method                                                                                                                                                                                                                                                                       Advantages                                                                                                                                                             Limitations
  --------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Estimation of neuroblasts migration patterns in fixed brain slices.   In fixed brain slices signs of neuroblasts migration are observed: distribution of cells from the supposed place of origin to the supposed destination; orientation of chains of cells and cell processes in the direction toward the destination.                                              It is a non-invasive and simple research method that facilitates the estimation of cell migration in the brain at the time of animal euthanasia.                       This approach facilitates the estimation of the direction of migration only of the cells migrating at the time of animal euthanasia. Furthermore, although the distribution of neuroblasts in the fixed brain slice describes the general direction of migration, it fails to prove the origins and direction of migration of each cell.
  Local administration of antimitotic agents.                           The Ara-C antimitotic agent is administered into a particular brain region to suppress neurogenesis in it.                                                                                                                                                                                      The method facilitates the reduction or exclusion of any participation of a brain region in replenishment with neurons in another region.                              The method is invasive and potentially causes adverse effects. The results of such experiments can be unequivocally interpreted only in the absence of any effects, i.e., when killing proliferating cells in one region doesn't affect the number of new neurons in the other.
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               Moreover, antimitotic drugs can diffuse in brain tissue from the region of injection to the remote brain areas. Thus, spatial specificity of antimitotic effect should be carefully verified.
  Surgical separation of brain regions.                                 Surgical separation prevents migration from one brain region into another.                                                                                                                                                                                                                      This method facilitates the exclusion of any participation of a brain region in replenishment with neurons in another region.                                          The method is invasive, and potentially causes adverse effects.
  Local labeling of cells in the brain.                                 Local administration of stains or genetic vectors carrying the reporter gene. Alternatively, transgenic animals can be administered with special agents that induce expression of a reporter gene in them (tamoxifen or a genetic vector with the recombinase gene can serve as an inductor).   This method helps prove the origin of a particular neuron from a particular brain region. Moreover, the method is suitable for direct observation of cell migration.   The method is invasive, and potentially causes adverse effects.
  Direct observation of cell migration in live brain slices.            Preliminary *in vivo* staining of neuroblasts, obtaining of live brain slices and detection.                                                                                                                                                                                                    The method facilitates a detailed observation of individual cell behavior.                                                                                             The conditions in the live brain slice cannot be equal to the conditions in the live animal brain: cutting the brain into slices results in damage to many cells, and isolating a slice from the whole brain removes potential influences from other cells in the whole brain. Moreover, brain slices remain viable for quite a short time (usually studies last up to one day), which is not enough to observe the long-term fate of migrated cells.
  Direct observation of *in vivo* cell migration.                       Preliminary *in vivo* staining of neuroblasts and subsequent bioluminescent or MRI detection. Alternatively, two-photon microscopy through a cranial window.                                                                                                                                    The method facilitates the tracing of long-term cell migration in the live brain.                                                                                      In general, the method has a low-resolution capacity, as it facilitates the observation of the migration of only large cell groups. However, a recently developed technique of intravital microscopy through a cranial window, in combination with two-photon microscopy, facilitates the tracing of individual cells deep within the brain tissue. Still, cranial window is a highly invasive approach.
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               

Early Postnatal and Adult Neurogenesis in the Normal Brain
==========================================================

In this section we summarize the data accumulated to date about the origins of NPCs and their migration pathways in the normal mammalian brain during the early postnatal and adult periods.

The Ventricular-Subventricular Zone
-----------------------------------

The V-SVZ is the main neurogenic niche and the major source of new neurons in the postnatal brain, both in the early postnatal period and throughout adulthood. This is a place where NSCs reside and NPCs originate. Many authors have recently used the general term, V-SVZ, to describe several regions located in the walls of the lateral ventricles ([@B91]). The SVZ, which stretches along the lateral wall of the lateral ventricles, is a major focus of studies ([@B35], [@B34]; [@B12]; [@B48]; [@B76]; [@B136]; [@B162]; [@B7]; [@B33]; [@B110]; [@B37]). Additionally, there are data on NSCs in a ventral extension of the lateral ventricle ([@B194]) and in the PPV region ([@B120]; [@B17]; [@B1]; [@B145]).

Neural stem cells in the V-SVZ, the so-called type B1 cells, have many characteristics of parenchymal astrocytes because they express GFAP, glutamate aspartate transporter (GLAST), and brain lipid-binding protein (BLBP) ([@B91]). However, unlike parenchymal astrocytes, type B1 cells have a direct contact with the ventricle. A subset of these cells is quiescent NSCs, whereas others are mitotically active ([@B97]). In the activated state, type B1 cells also express Nestin and produce transit-amplifying precursors (type C cells) that produce NPCs (type A cells) expressing the markers of immature neurons ([@B91]). The NPCs that originate in the V-SVZ migrate to other brain regions where they finally differentiate into neurons and may integrate into local neural networks ([@B96]; [@B146]).

In the early postnatal brain, several migratory pathways stretching from the V-SVZ to other brain regions have been described. [@B60] showed in fixed and cultivated mouse brain slices that in the first weeks of life, neuroblasts travel along four different pathways -- rostral, ventral, external, and dorsal -- from the lateral ventricles. The rostral migratory stream (RMS) flows from the SVZ to the OB; the ventral stream flows from the SVZ to the striatum and the nucleus accumbens; the external migratory pathway emerges from the anterior parts of the SVZ and extends along the external capsule toward the latero-dorsal regions; the dorsal stream flows from the PPV along the superior border of the hippocampus toward the occipital cortex. Other authors also report on the massive migration of neuroblasts from the SVZ as well as from the RMS via the corpus callosum to the cortex ([@B28]; [@B83]). In the cortex, migrating neuroblasts mainly reach the lower layers ([@B28]; [@B60]; [@B83]), but can be also found in the upper layers ([@B28]; [@B60]).

[@B30] injected CellTracker Green into the SVZ of newborn mice and showed three migratory pathways for neuroblasts originating in the SVZ: primarily, the RMS and two additional pathways -- ventral migratory mass (VMM) and ventrocaudal migratory stream (VMS). Within the VMM, neuroblasts migrate from the SVZ to the basal forebrain and populate the islands of Calleja, while the VMS deviates from the anterior part of the RMS to flow in the ventrocaudal direction, when neuroblasts reach the pyramidal layer of the olfactory tubercle.

In the adult brain, the V-SVZ remains the main zone of neurogenesis. However, its intensity decreases soon after birth and the majority of pathways become largely quiescent ([@B45]). The exception is NPC migration from the SVZ to the OB, which remains active in adulthood, at least in rodents ([@B91]). Cells migrate in chains and form an RMS stretching from the SVZ to the OB. In the OB, neuroblasts then migrate radially and turn into mature neurons in the granular and periglomerular layers ([@B159]).

The migration from the V-SVZ to other brain regions substantially decreases compared with the early postnatal period, and a range of works have confirmed this. [@B30] found that migration via the VMS to the olfactory tubercle, which was observed in neonatal mice, is less intense during adulthood, whilst migration within the VMM stops completely. Several other studies report on the occurrence of neuroblasts and new mature neurons in different areas of the adult mouse and rat brains, including the striatum, nucleus accumbens, ventral septum, corpus callosum, olfactory tubercle, anterior olfactory nuclei, tenia tecta, islands of Calleja, amygdala and lateral entorhinal cortex ([@B27]; [@B161]; [@B150]). The origin of these neurons has not been established. However, the authors posit that they are produced in the SVZ ([@B27]; [@B161]; [@B150]). [@B194] labeled NPCs localizing near the lateral ventricles with DiI injection into the lateral ventricle, and demonstrated that neuroblasts migrate from a ventral extension of the lateral ventricle to the substantia nigra, where they differentiate into dopaminergic neurons. [@B120] administered DiI or a genetic vector with a GFP gene into the lateral ventricle of a normal animal, and showed negligible migration of stained neuroblasts from the PPV toward CA1 of the hippocampus.

Despite the fact that these pathways remain largely quiescent ([@B45]), they might be important for response to injury. Multiple studies on the injured brain showed significant intensification of NPC migration in these conditions ([@B8]; [@B120]; [@B165]).

In humans, the amount of neuroblasts migrating to the OB drops rapidly in the early postnatal period. [@B156] using the ^14^C technique showed that in the OB, adult neurogenesis can be negligible. As in animal models, neurogenesis in the SVZ in humans declines over a lifetime ([@B32]).

The Hippocampus
---------------

The DG of the hippocampus ranks second after the V-SVZ where proliferation of NPCs continues throughout the whole life of animals. According to the classical point of view, the dentate neuroepithelium gives rise to both granular neurons and NSCs in the prenatal period ([@B52]). However, recent studies of [@B87] showed that the NSCs in the DG may originate from the population in the most ventral part of the hippocampus, close to the lateral ventricle. These cells migrate to the DG at the late stage of gestation and become the source of NSCs of the SGZ in adulthood. Proliferation in the DG is limited to the SGZ from the second postnatal week ([@B167]). Radial glia-like cells (RGL), also called type 1 cells that express GFAP, Nestin, and SOX2, are considered as genuine NSCs in the SGZ ([@B52]). Most of these cells remain quiescent and eventually divide ([@B40]).

Unlike the SVZ ([@B126]), neurogenic potential of NSCs in the SGZ is highly debated. [@B15] showed self-renewal properties and multipotent capacity of RGL cells, using cloning analysis. At the same time, the studies of Encinas and Enikolopov, based on the Nestin-GFP transgenic mice ([@B109]), showed restriction of the NSC pool and its inability to self-renew. Moreover, the authors, using multiple S-phase labeling, observed that RGL cells in the SGZ make 2-3 asymmetric divisions and then lose their RGL morphology. Further they move to the hilus where they start expressing S100ß (a marker of mature astrocytes) and continue to express GFAP but not Nestin ([@B40]). The number of RGL cells dramatically drops with age ([@B48]; [@B40]; [@B111]; [@B11]).

Asymmetric division gives rise to bipolar neural progenitors that differentiate into neuroblasts after several divisions. During their maturation these NPCs, unlike NPCs from the V-SVZ, migrate short distances -- from the subgranular to the granular layer of the DG -- and become mature glutamatergic granular neurons ([@B48]; [@B6]; [@B162]; [@B33]; [@B110]; [@B37]; [@B59]).

In adult humans, hippocampal neurogenesis in the DG is more prominent than in the OB ([@B48]; [@B156]; [@B63]). [@B156] showed two different types of neuronal populations in the human hippocampus, one of which is renewed continuously, unlike the other. The renewing cell population accounts for approximately one third of the hippocampal neurons and exceeds similar cell population in rodents ([@B153]). In humans, as in rodents, hippocampal neurogenesis declines over the years ([@B58]). It is worth noting that despite the large number of research works, inconsistency still exists concerning the abundance of adult human hippocampal neurogenesis. For example, two recent studies have provided quite contradictory results. [@B114] found thousands of cells of immature neuronal phenotype within the DG of healthy adult subjects, aged between 43 and 87. In sharp contrast, [@B155] report that hippocampal neurogenesis declines in children and no immature neurons are found within the DG in adult subjects. [@B114] along with [@B68] consider that such discrepancies may stem from the differences in the details of post-mortem tissue processing, and conclude that the level of human hippocampal neurogenesis may in fact be underestimated in some studies due to the loss of the detectable immature neuronal markers in post-mortem brain tissues. Thus, a consensus about the level of adult human hippocampal neurogenesis is yet to be achieved.

The Cortex
----------

Neurogenic potential of the cerebral cortex in physiological conditions is considerably smaller in comparison to the V-SVZ and to the SGZ of the DG.

The majority of cortical neurons and glial cells originate from the radial glia stem cells that located along lateral ventricles. These cells generate cortical neurons and direct their migration to the cortical layers at the embryonic stage ([@B141]). This process is almost complete prior birth. However, the mouse cortex retains its neurogenic potential for a short period after birth. For almost 10 days after birth, there exist in the mouse cortex multipotent astrocytic stem cells, which, having been translated into cell culture, form neurospheres and differentiate into neurons, astrocytes and oligodendrocytes ([@B82]; [@B3]). From day 10 neurogenesis in the cortex stops; however, traumatic injury of the cortex at day 15 causes its restoration ([@B3]).

Almost no neurogenesis occurs in the cortex of the normal adult brain in rodents, but systematic analysis shows that small numbers of NeuN/BrdU double positive new neurons still continue to be generated there ([@B27]). Their origin has yet to be established, but the authors posit that these neurons might be produced from local precursors. Interestingly, these new neurons seem to be generated not from DCX-expressing cells but, rather, from those that express NG2, a protein that is usually associated with oligodendrogenesis. There were no DCX-expressing cells in the cortex, but instead there were proliferating (BrdU-labeled) NG2-positive cells. Moreover, some NeuN/BrdU positive cells also co-expressed NG2, suggesting that NG2-precursors are the source of new neurons in the cortex. Given that DCX is a marker of migrating neuroblasts, the authors concluded that the observed cortical DCX-negative progenitors are of local origin ([@B27]). [@B54] similarly showed rare cells incorporating BrdU and co-expressing the neuronal markers NeuN and TuJ1 in the anterior rat neocortex. It remains unclear whether these cells are of local origin or they arise from the SVZ. At the same time, some other studies failed to discover any newly generated neurons in the adult rodent cortex ([@B38]; [@B102]). However, analysis performed in the review by [@B19] suggests that the causes for such negative results may stem from an extremely low level of cortical neurogenesis and the small diameter of their nuclei.

A number of studies in primates and humans mainly report on the absence or a low level of adult neurogenesis in the cerebral cortex. Longitudinal observations by [@B54] revealed a small number of cells that co-expressed the neuronal markers NeuN and TuJ1 with BrdU. The authors concluded that these *de novo* generated neurons have transient existence because their number declines after 9 weeks of observation. The origin of these cells has not been studied in this work. In humans, Eriksson's studies ([@B41]) showed a non-neuronal phenotype of BrdU-labeled cells in the cortex. An extremely sensitive analysis, which included both BrdU labeling and ^14^C incorporation, estimated the exchange rate of neurons in the adult human neocortex at 1/1,000 neurons every fifth year ([@B13]).

For several decades, the piriform cortex has attracted significant attention due to its ability to express the markers of immature neurons DCX and PSA-NCAM, which was revealed in most mammalian species in adulthood. Nevertheless, numerous attempts to achieve evidence of neurogenesis in this area using BrdU labeling failed. It was concluded that the expression of DCX and PSA-NCAM could be explained by this particular population of neurons retaining its structural plasticity ([@B116]).

The Striatum
------------

The adult striatum, at least in some mammalian species, also retains the potential to generate new neurons. Ontogenically, the striatum originates from the ganglionic eminence located in the ventral part of the developing telencephalon. The most active striatal neurogenesis, which proceeds in two phases that result in a different functionality of striatal neurons, almost ends with birth ([@B135]). In adults the striatum consists of about 95% GABAergic medium spiny neurons and less than 5% aspiny interneurons ([@B163]; [@B135]).

Unlike the cerebral cortex, there is significantly more evidence of the generation of new neurons in the adult striatum under physiological conditions. Several works did not reveal new neurons in the unlesioned striatum ([@B137]; [@B164]; [@B100]). Nevertheless, some studies clearly demonstrated that neuroblasts and new neurons continued to arise in the striatum of adult rats ([@B27]), rabbits ([@B99]), guinea pigs ([@B101]) and humans ([@B42]). However, adult-born new neurons were not found in mice in physiological conditions ([@B121]), suggesting a potentially important difference between the species. In humans, unlike in other species, [@B42] showed substantial neurogenesis in the striatum: a subpopulation of interneurons, mainly expressing the marker calretinin, is exchanged at a rate of 2.7% per year in adulthood.

The origin of NPCs in the adult striatum has been intensively studied. Some works have largely clarified the question concerning "local vs. SVZ" source of these neurons. [@B99], analyzing spatial distribution of proliferating NPC clusters in rabbits, have demonstrated that new neurons in the striatum, at least partially, are of local origin. The authors also showed that NPCs differentiate into mature neurons; however, only a small amount of them survive during maturation. Similarly, NSCs of astroglial nature, like NSCs in the SVZ and DG, were found in the external capsule and lateral striatum of juvenile guinea pigs ([@B101]). These cells proliferate and give rise to new neurons that have existed transiently and have not contributed to the population of mature functional neurons. At the same time, they expressed Sp8, a transcription factor associated with neuroblasts migrating to the OB, and showed tropism for white matter tracts. Collectively, these studies suggest that the striatum, at least in rabbits and guinea pigs, is able to generate new neurons but that their survival is negligible.

Various pathologic changes and injuries strongly affect neurogenesis and migration of NPCs in the adult brain. Though the V-SVZ is still considered the main source of new neurons, migration pathways and destinations of NPCs can change depending on lesion area. At the same time, there is much evidence that new neurons can originate from different sources outside the known and proven neurogenic zones. In the next section we consider several works investigating these changes.

Neurogenesis in the Injured Brain
=================================

In this section we describe changes in proliferation and migration of NPCs in the injured brain. In general, injury can stimulate V-SVZ neurogenesis accompanied by the migration of V-SVZ-derived neuroblasts to the site of injury, as well as local generation of new neuroblasts near the damage area. In the latter case, new neuronal progenitors are found to arise from local astrocytes, which gain NSCs properties. The significance of SVZ-derived versus local progenitors is a highly debated question. [Table 2](#T2){ref-type="table"} summarizes the research described in the following sections.

###### 

Data on the origins of new neurons in the damaged brain.

  Model of brain injury                        Brain region   References                           
  -------------------------------------------- -------------- ------------ ----- ----- ----- ----- -------------------------------------------------------------------------------------------------------------
  Global ischemia                                             Yes                                  [@B120]
                                                              Yes                                  [@B131]
  MCAO                                                                     No    Yes               [@B176]
                                                                           Yes                     [@B104]; [@B36]
                                                                                 Yes               [@B8]; [@B190], [@B193], [@B191], [@B192]; [@B165]; [@B57]; [@B93]; [@B73]; [@B88]; [@B119]; [@B55]; [@B67]
  Neonatal ischemia/hypoxia                                                      Yes               [@B182]; [@B181]
  Global ischemia                                                                Yes               [@B185]
  Hemorrhagic stroke                                                             Yes               [@B178]
  MCAO                                                                           Yes         Yes   [@B134]; [@B64]; [@B188]; [@B177]
  Global ischemia                                                                      Yes   Yes   [@B128]
                                                                                       Yes         [@B47]
  Neonatal hypoxia                                                                     Yes         [@B14]
  MCAO                                                                                 Yes   No    [@B78]
  Chemical injury of the cortex                                                        No    Yes   [@B44]
                                                                                             Yes   [@B103]; [@B20]; [@B43]
  Global ischemia                                                                            Yes   [@B90]
  MCAO                                                                                       Yes   [@B85]; [@B173]; [@B80]; [@B86]; [@B77]; [@B113]; [@B132]; [@B140]
  MCAO+global ischemia                                                                       Yes   [@B127]; [@B154]; [@B166]
  Photothrombotic stroke (cortex)                                                            Yes   [@B130]; [@B169]
  Thermocoagulation of pial vessels (cortex)                                                 Yes   [@B53]
  Cortical devascularization                                                                 Yes   [@B75]; [@B171]
  Neonatal ischemia/hypoxia                                                                  Yes   [@B180]
  Mechanical injury of the cortex                                                            Yes   [@B49]; [@B142]; [@B145]; [@B183]
                                                                                                   

New Neurons in the Damaged Hippocampus -- Resident and Migrating From the PPV Region
------------------------------------------------------------------------------------

As has already been mentioned, under physiological conditions significant neurogenesis occurs in the DG of the hippocampus. Under ischemic conditions, mainly in the model of global ischemia, the number of neuroblasts in the DG can grow ([@B148]; [@B10]; [@B175]; [@B69], [@B70]).

Additionally, after global ischemia new neurons are detected in the CA1 region of the hippocampus, where in these conditions a massive death of pyramidal neurons occurs ([@B120]; [@B148]; [@B25]; [@B10]; [@B131]; [@B175]). The PPV is probably the major source of these new neurons in CA1. This supposition is lent credence by the work of [@B120] who, having labeled the cells from the PPV by intraventricular administration of DiI or of a vector with a GFP gene, proved that under total ischemic conditions neuroblasts migrate from the PPV. Moreover, the authors showed that a small number of neuroblasts from the PPV also migrate to the DG. Some authors revealed post-ischemic distribution of neuroblasts from the PPV to CA1 in fixed slices ([@B131]; [@B71]). Furthermore, it is likely that the same migration was being reported in the work by [@B25], wherein the authors discovered an increase, after neonatal hypoxia, in the number of neuroblasts in the SVZ and the PPV, where labeled cells formed a migrating chain toward the periventricular region located above the hippocampus. Many works that have demonstrated the appearance of young neurons in CA1 after ischemia still provide no information about their origins ([@B148]; [@B10]; [@B175]; [@B124]; [@B129]). [@B10] emphasized that after ischemia NPCs proliferation increased both in the PPV and the SGZ of the DG, and both these regions could be the source of new neurons in CA1.

Thus, these data testify that new neurons in the damaged CA1 region originate from the PPV. However, there is no proof that resident NPCs cannot occur in this region after an injury, because this possibility has not been specifically examined.

New Neurons in the Damaged Striatum -- Resident and Migrating From the SVZ
--------------------------------------------------------------------------

In the damaged striatum, many young neurons can be detected, as has been shown on models of ischemia ([@B64]; [@B176]; [@B57]; [@B73]; [@B55]; [@B104]) and neonatal ischemia-hypoxia ([@B182]; [@B181]).

Some works do not specify the origins of these cells ([@B72]; [@B84]; [@B189], [@B186]; [@B107]; [@B184]; [@B24]; [@B178]; [@B152]; [@B90]; [@B129]; [@B21]; [@B46]; [@B172]). However, some proved their origins from the SVZ using different methods by:

1.  labeling cells in the SVZ ([@B64]; [@B188], [@B193], [@B192]; [@B176]; [@B57]; [@B181]; [@B93]; [@B73]; [@B88]; [@B185]; [@B55]);

2.  direct observation of migration in living brain slices ([@B193], [@B191]; [@B73]; [@B55]);

3.  intraventricular administration of the antimitotic agent Ara-C ([@B185]);

4.  or estimation of neuroblasts distribution in fixed brain slices ([@B8]; [@B134]; [@B64]; [@B190], [@B188], [@B193], [@B191], [@B192]; [@B165]; [@B182]; [@B177], [@B179]; [@B181]; [@B93]; [@B88]; [@B185]; [@B119]; [@B67]).

Additionally, data provided by [@B176] suggest that SVZ-derived NPCs can be the main source of new neurons in the damaged striatum after transient MCAO, with no, or minor, participation of local striatal progenitors. For labeling cells that originate from the striatum, a genetic vector carrying the GFP gene was injected into the striatum. As a result, GFP expression was induced in some striatal cells (in the majority of cells near the injection site), but not in the SVZ. Then, ischemia was induced, and none of the detected DCX-positive neuroblasts in the damaged striatum expressed GFP. However, given that only a subset of striatal cells was infected with a GFP-expressing vector, the generation of new neurons from some unlabeled striatal progenitors cannot be entirely excluded. At the same time, DCX-positive neuroblasts in the damaged striatum expressed GFP, if the vector was injected into the SVZ. This points to a significant role for SVZ-derived progenitors.

At the same time, three works proved that after lesion, a number of new neurons in the striatum are generated from local precursors ([@B104]; [@B36]; [@B121]). [@B121] found local neurogenesis in the damaged striatum after excitotoxic lesion. By injecting a vector carrying Cre-recombinase under the control of a GFAP promoter into the striatum of transgenic R26R reporter mice, the authors induced YFP expression in striatal -- but not subventricular -- astrocytes. After subsequent lesion, about 85% of clustering Ki67 and DCX-positive cells in the damaged striatum co-expressed a YFP reporter, indicating that the majority of lesion-induced neuroblasts are of local origin. Additionally, the induction of a YFP reporter in the SVZ revealed that only a small number of these striatal neuroblasts derived from the SVZ. Similarly, [@B104] induced the expression of the YFP gene in the striatal astrocytes and their offspring (but without induction of YFP expression in the SVZ or the RMS). After ischemia, which was later induced, many cells that had expressed YFP were also colocalized with DCX and with NeuN. [@B36] induced GFP expression in astrocytes of the striatum by injecting a vector carrying a GFP gene under the control of a GFAP promoter. After ischemia they discovered NeuN- and Nestin-positive cells among those that had expressed GFP. The authors concluded that these cells are GFP-positive because they had generated from striatal GFAP-expressing astrocytes. However, it is unclear whether cells are able to retain a detectable amount of GFP in the absence of GFP-gene expression for an any significant length of time. Thus, the exact mechanism of GFP appearance in GFAP-negative neurons and NPCs remains an open question and the results of [@B36] are difficult to interpret.

It should be noted here that the majority of the above-mentioned works estimated the role of either the SVZ or only of the striatum in the production of new neurons in the damaged striatum. Only the two works investigated both and obtained contradictory results ([@B176]; [@B121]). In particular, [@B176] failed to discover new striatal neurons of local origin at all, whereas [@B121] found that the majority of lesion-induced striatal neuroblasts are of local origin. It is unclear whether these contrasting results stem from the difference in the nature of the lesion (transient local ischemia versus chemical lesion), or from some other methodological aspects of the studies. At the same time, the work by [@B88], who labeled the cells originating from the SVZ, showed that labeled cells from the SVZ account for only one third of all neuroblasts in the damaged striatum. However, it remains unclear whether this value is indicative of the actual proportion of subventricular/striatal precursors or of insufficient labeling of precursors in the SVZ. Thus, it remains to be elucidated which plays a more important role in the restoration of the damaged striatum -- the SVZ or the striatum.

New Neurons in the Damaged Cortex -- Resident and Migrating From the SVZ/PPV Region
-----------------------------------------------------------------------------------

Damage to the cortex of the adult animal brain enhances neurogenesis in it, and this has been shown in different models of brain damage, such as ischemia ([@B64]; [@B127]; [@B75]; [@B77]; [@B128]), neonatal ischemia-hypoxia ([@B180]), neonatal hypoxia ([@B14]), and mechanical ([@B145]), chemical ([@B43], [@B44]) and thermal ([@B23]; [@B4]) damage. Some of the above works do not include an investigation into the origins of new neurons in the damaged cortex ([@B189]; [@B184]; [@B23]; [@B129]; [@B4]).

The majority of works establish their origin from the SVZ or from the PPV. These findings were obtained with the use of different approaches based on:

1.  distribution pattern of neuroblasts migrating from the SVZ/PPV to the damaged area in fixed brain slices ([@B103]; [@B134]; [@B64]; [@B20]; [@B49]; [@B53]; [@B142]; [@B188]; [@B127]; [@B75]; [@B85]; [@B173]; [@B177]; [@B43], [@B44]; [@B89], [@B86]; [@B90]; [@B77]; [@B130]; [@B145]; [@B183]; [@B113]; [@B169]; [@B171]; [@B132]; [@B140]; [@B154]; [@B166]);

2.  suppression of cell proliferation in the SVZ by intraventricular administration of Ara-C ([@B85]; [@B86]; [@B44]);

3.  labeling cells from the lateral ventricles ([@B64]; [@B49]; [@B142]; [@B188]; [@B127]; [@B75]; [@B180]; [@B43], [@B44]; [@B80]; [@B77]; [@B86]; [@B145]; [@B169]);

4.  and direct observation of migration in the live brain ([@B169]).

At the same time, some studies do in fact suggest that the production of new neurons can occur in the injured cortex ([@B56]; [@B78]; [@B128]; [@B152], [@B151]; [@B14]; [@B118], [@B117]; [@B47]). [@B14] showed by special labeling that, after neonatal hypoxia, cortex astrocytes in neonates gain the properties of NSCs and differentiate into new neurons both in the damaged cortex and after having been translated into cell culture.

[@B128] discovered, in the first layer of the normal animal cortex, proliferating cells that express the GAD67 neuronal marker. Mild ischemia, which was achieved by 10-min cross-clamping of the two major carotid arteries, caused an increase in the number of these cells, their migration into the lower layers of the cortex and differentiation into functionally mature neurons (revealed by expression of the TuJ1, HuC/D, MAP2, c-Fos markers, and electrophysiological activity). A vector with the GFP reporter gene was administered before ischemia either into the cortex or into the SVZ to determine the source of new neurons in the cortex. The cortex appeared to be the main source of new neurons itself, with only a few having migrated to the cortex from the SVZ.

[@B78] report in their work that after transient MCAO new neurons were generated in the cortex. The authors emphasize that they have not detected any patterns of neuroblasts migration from the SVZ via the corpus callosum to the cortex. Therefore, they assume that these new neurons in the cortex are of local origin.

[@B47] described in their work that after 10-min cross-clamping of the two carotid arteries they observed proliferation of GAD67-positive NPCs in the cortex. The fact that these cells localized mainly in the first layer showed that they were local precursors.

[@B56] reported in their work that after phototrombotic stroke new neurons (colocalization of bromodeoxyuridine with MAP2 and NeuN) started generating in the damaged cortex 72 h after surgery. The authors concluded that this early appearance of new neurons in the cortex proves that it is very unlikely that they could have originated in the SVZ. At the same time, it is questionable that even local progenitors in the cortex can generate mature NeuN-expressing cortical neurons within 3 days. Thus, the mechanism of new neuron generation in this study remains unclear.

Some works described that after permanent MCAO in adult animals, cortical astrocytes ([@B16]; [@B152], [@B151]), as well as pericytes of leptomeningeal and cortical vessels ([@B118], [@B117]), gained NSC properties: in cell culture they differentiate into neurons, astrocytes and oligodendrocytes. At the same time, in the damaged cortex these precursors exhibited a more limited capacity to differentiate -- differentiating only into astrocytes and oligodendrocytes and never into neurons ([@B16]; [@B152]).

Despite a large number of studies, it is still difficult to get a full picture of neurogenesis in the damaged cortex since the majority of researchers estimated the role of either only the cortex or of the SVZ in the production of new cortical neurons. The work by [@B128] is a rare exception. The authors labeled both cells of the cortex and cells of the SVZ, and demonstrated that after a mild cortical ischemia a larger part of new cortical neurons originated in the cortex, not in the SVZ. At the same time, [@B44] showed that after chemical cortical damage, all of the NPCs that were generated in the cortex had originated from the SVZ. The different results allow us to assume that the role of local and SVZ precursors in the restoration of the cortex can substantially vary depending on the conditions of the experiment, particularly on the type and degree of damage.

Interhemispheric Migration
--------------------------

In this section we consider several works that describe interhemispheric migration of neuroblasts after cortical injury ([@B142]; [@B171]). The authors discovered that damage to the cortex may result in migration of neuroblasts from one hemisphere to the other. While [@B171] reported on migration from the healthy hemisphere to the damaged one, [@B142] discussed migration from damaged to healthy.

[@B171] observed that after cortical devascularization, migration occurs not only from the SVZ of the same hemisphere, but also from the contralateral SVZ, to the injured cortex. In fixed brain slices, the authors observed distribution of cells migrating from the contralateral SVZ via the midline, further to the ipsilateral corpus callosum, and finally to the lesion area in the cortex. Some authors report on the enhancement of proliferation in the contralateral SVZ after ischemic or mechanical brain damage but they have not found any signs of migration from the contralateral SVZ to ipsilateral ([@B85]; [@B77]; [@B86]; [@B145]).

[@B142] obtained more unusual results. They discovered that after mechanical damage to the cortex, neuroblasts migrate from the ipsilateral SVZ not only to the lesion area in the cortex, but also to the contralateral (non-damaged) hemisphere. The origin of neuroblasts migrating from the SVZ has been proved by preliminary administration of fluorescent microspheres into the lateral ventricle. The authors hypothesized that migration of neuroblasts to the contralateral hemisphere may functionally compensate for the damage to the ipsilateral cortex, hence the healthy cortex in the contralateral hemisphere may take over the functions of the damaged cortex. The results obtained by the two mentioned groups ([@B142]; [@B171]) are extraordinary, and have not been reported elsewhere. Still, it remains unclear whether migration from the damaged hemisphere to the health one or vice versa occurs only under some specific conditions set by researchers, or is an ordinary process in the injured brain that has just been overlooked by other investigators.

Functional Relevance of Injury-Induced Neurogenesis
---------------------------------------------------

Although this review focuses mainly on the anatomical origin of new neurons appearing in the damaged brain areas, the question about their functional relevance cannot be ignored due to its high importance when seeking out new directions for future therapies. Here we discuss some related issues. For more information about the survival, differentiation and functional integration of new neurons within the injured brain tissue, we direct the reader to the reviews by [@B92] and [@B105].

Relatively few works have addressed the study of structural and functional integration of new neurons into the existing neural networks after brain injury. Mainly, such integration has been shown in the damaged striatum and cortex.

At least two studies provided evidence that both SVZ-derived and locally generated neurons may successfully integrate into the pre-existing circuit within the damaged cortex. [@B80] used lentiviral labeling of SVZ-derived progenitors in combination with patch-clamp recordings on the labeled neurons within the cortex. They showed that after MCAO, new SVZ-derived neurons in the damaged cortex fired the induced and spontaneous action potentials, which suggests that these neurons are synaptically integrated. However, the results of [@B80] should be interpreted with consideration for the fact that a lentiviral vector could have infected non-dividing cells in the cortex. [@B128] retrovirally labeled the local progenitors within the cortex, and after global ischemia indirectly examined the functional integration of new neurons by evaluation of the immediate early gene c-Fos expression. They found that c-Fos expression by the new neurons was much higher in the enriched environment when compared with the control conditions, which suggests that the new neurons in the cortex are synaptically active. It was also concluded that the new neurons are GABAergic interneurons.

Several studies showed structural and functional integration of new neurons into the existing striatal networks. [@B176], using electron microscopy, showed that newly generated neurons form synapses with neighboring cells in the post-ischemic striatum. Additionally, a retrograde tracing study by [@B160] showed that a subpopulation of new neurons in the damaged striatum re-establishes long connections with the substantia nigra. Moreover, [@B57] provided both structural and electrophysiological evidence of synaptic integration of new striatal neurons after MCAO. Strong evidence in support of the regenerative role of lesion-induced neurogenesis comes from the work by [@B65]. The authors used transgenic animals expressing herpes simplex virus thymidine kinase under the control of the promoter for DCX to selectively ablate new neurons in the brain through a ganciclovir injection. They showed that neurogenesis ablation worsens the outcome after MCAO at both histological and behavioral levels.

Despite these optimistic results, the majority of these studies showed two important limitations in the restoration of neuronal circuits by adding newly generated neurons: the low survival rate of these neurons and the poor scope of their differentiation potential. Most new neurons within the ischemic striatum die, possible due to unfavorable environment in the damaged tissue ([@B8]; [@B134]; [@B165]). Since generation and migration of new neurons can last for months ([@B165]; [@B85]) and even a year ([@B74]; [@B130]) after injury, we can assume that mature neurons may, at least partially, compensate for their high mortality within the ischemic tissue.

Another important limitation is a relevance of functional features of integrated new neurons to the pre-existing functionality of the network. Studies on a phenotype of newly generated neurons within the ischemic striatum provided contradictory results regarding a percentage of newly generated neurons expressing DARPP-32, a marker of medium-sized spiny neurons -- the major class of striatal neurons. [@B8] and [@B134] showed that after MCAO a substantial number of new striatal neurons are DARPP-32-positive. In contrast, on the same model of ischemia, [@B164] and [@B93] failed to find any newly generated DARPP-32-positive neurons at all. [@B164] found that about 65% of newly generated striatal neurons are parvalbumin-positive interneurons, which normally comprise a minor subpopulation of striatal neurons. [@B93] reported that nearly all new neurons in the damaged striatum are calretinin-positive interneurons, which are extremely rare in the striatum under physiological conditions. In addition, these new striatal neurons express the transcription factor Sp8, which is expressed in most newly generated neurons in the OB under physiological conditions. The results of [@B93] suggested that SVZ-derived progenitors had strictly limited differentiation potency, and that after MCAO they cannot generate the majority of neuronal classes, which are lost within the damaged striatum. This point of view may be further strengthened by the work of [@B108]. The authors found that, despite the diversity of the newly generated OB interneurons, their stem progenitors within the SVZ have a strictly restricted potency of differentiation. In fact, the SVZ stem cell niche has a mosaic organization, where NSCs from SVZ subregions vary in their differentiation potential. NSCs from a particular SVZ-subregion may give rise only to a particular type of interneurons, even when cultivated *in vitro*. It seems unlikely that these strictly predetermined cells can produce other types of neurons necessary for brain recovery.

Identification of the causes of the above-mentioned discrepancies is one of the directions for future studies. Thus, more research needs to be done to comprehensively evaluate the regenerative potential of adult neurogenesis and to develop optimal strategies for its enhancement.

Conclusion
==========

Up to the present time, a substantial amount of research material concerning the origins and migratory pathways of NPCs in the brain under physiological and pathological conditions has been accumulated. In the healthy brain, the majority of NPCs originate in the V-SVZ located in the walls of the lateral ventricles ([@B91]). In the embryonic and early postnatal brain, NPCs migrate from the V-SVZ to the OB, striatum, and cortex. In adulthood, these pathways -- except for migration to the OB in rodents ([@B91]) and, probably, to the striatum in humans ([@B42]) -- remain substantially quiescent but can intensify in conditions of brain injury ([@B120]; [@B176]; [@B44]). Among other regions, at the very least, the adult striatum maintains the capacity to generate new neurons in both physiological ([@B27]; [@B99], [@B100]) and pathological ([@B104]; [@B121]) conditions. The fate and functionality of local newborn striatal neurons have been intensively studied ([@B92]; [@B105]). Adult neurogenesis in the cortex and migration of NPCs from the V-SVZ to this area in physiological conditions are less evident ([@B54]; [@B27]; [@B13]; [@B19]). However, whilst brain injury provokes the generation of new cortical neurons, the survival and functionality of these neurons are commonly questioned ([@B128]; [@B44]).

Human neurogenesis, which has been also shown in the studies with the comprehensive ^14^C-content assessment ([@B156]), substantially differs from neurogenesis in rodents. Using this technique in studies on rodents, which are more extensively used in research, could help clarify these differences.

Despite the impressive array of research works, at present there is no full picture of neurogenesis and NPC migration in the brain. Most research works address either a single neurogenic region or a single migratory pathway of neuroblasts. Future studies on the injured brain could examine the following aspects: firstly, the local or migratory nature of NPCs after brain injury could be confirmed by novel techniques of real-time observations; secondly, since the presence of newly generated neurons does not ensure their functionality, the question about the integration of new neurons into the existing networks and their phenotypes could be further investigated; thirdly, comparative studies are needed to understand the difference between human and rodent neurogenesis for future translation of new therapies to clinic.

It is likely that in the future, methods for longitudinal observation capable of capturing new neuron production, migration, and functional integration in the same animal brain, will be improved. We believe that the advancement of methods for *in vivo* visualization of neurogenesis in the brain could fundamentally change the current situation in this field.
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